Literature DB >> 31811279

Microbiota in pancreatic health and disease: the next frontier in microbiome research.

Ryan M Thomas1,2, Christian Jobin3.   

Abstract

Diseases intrinsic to the pancreas such as pancreatitis, pancreatic cancer and type 1 diabetes mellitus impart substantial health and financial burdens on society but identification of novel mechanisms contributing to these pathologies are slow to emerge. A novel area of research suggests that pancreatic-specific disorders might be modulated by the gut microbiota, either through a local (direct pancreatic influence) or in a remote (nonpancreatic) fashion. In this Perspectives, we examine literature implicating microorganisms in diseases of the pancreas, specifically pancreatitis, type 1 diabetes mellitus and pancreatic ductal adenocarcinoma. We also discuss evidence of an inherent pancreatic microbiota and the influence of the intestinal microbiota as it relates to disease association and development. In doing so, we address pitfalls in the current literature and areas of investigation that are needed to advance a developing field of research that has clinical potential to reduce the societal burden of pancreatic diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31811279     DOI: 10.1038/s41575-019-0242-7

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  132 in total

1.  The rise of childhood type 1 diabetes in the 20th century.

Authors:  Edwin A M Gale
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

2.  Long-term Outcome and Causes of Death for Working-age Patients Hospitalized Due to Acute Pancreatitis With a Median Follow-up of 10 Years.

Authors:  Heikki Karjula; Arto Saarela; Pasi Ohtonen; Tero Ala-Kokko; Jyrki Mäkelä; Janne H Liisanantti
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

3.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Authors:  Leore T Geller; Michal Barzily-Rokni; Tal Danino; Oliver H Jonas; Noam Shental; Deborah Nejman; Nancy Gavert; Yaara Zwang; Zachary A Cooper; Kevin Shee; Christoph A Thaiss; Alexandre Reuben; Jonathan Livny; Roi Avraham; Dennie T Frederick; Matteo Ligorio; Kelly Chatman; Stephen E Johnston; Carrie M Mosher; Alexander Brandis; Garold Fuks; Candice Gurbatri; Vancheswaran Gopalakrishnan; Michael Kim; Mark W Hurd; Matthew Katz; Jason Fleming; Anirban Maitra; David A Smith; Matt Skalak; Jeffrey Bu; Monia Michaud; Sunia A Trauger; Iris Barshack; Talia Golan; Judith Sandbank; Keith T Flaherty; Anna Mandinova; Wendy S Garrett; Sarah P Thayer; Cristina R Ferrone; Curtis Huttenhower; Sangeeta N Bhatia; Dirk Gevers; Jennifer A Wargo; Todd R Golub; Ravid Straussman
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

4.  Orai1-Mediated Antimicrobial Secretion from Pancreatic Acini Shapes the Gut Microbiome and Regulates Gut Innate Immunity.

Authors:  Malini Ahuja; Daniella M Schwartz; Mayank Tandon; Aran Son; Mei Zeng; William Swaim; Michael Eckhaus; Victoria Hoffman; Yiyuan Cui; Bo Xiao; Paul F Worley; Shmuel Muallem
Journal:  Cell Metab       Date:  2017-03-07       Impact factor: 27.287

Review 5.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

6.  The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.

Authors:  Smruti Pushalkar; Mautin Hundeyin; Donnele Daley; Constantinos P Zambirinis; Emma Kurz; Ankita Mishra; Navyatha Mohan; Berk Aykut; Mykhaylo Usyk; Luisana E Torres; Gregor Werba; Kevin Zhang; Yuqi Guo; Qianhao Li; Neha Akkad; Sarah Lall; Benjamin Wadowski; Johana Gutierrez; Juan Andres Kochen Rossi; Jeremy W Herzog; Brian Diskin; Alejandro Torres-Hernandez; Josh Leinwand; Wei Wang; Pardeep S Taunk; Shivraj Savadkar; Malvin Janal; Anjana Saxena; Xin Li; Deirdre Cohen; R Balfour Sartor; Deepak Saxena; George Miller
Journal:  Cancer Discov       Date:  2018-03-22       Impact factor: 39.397

7.  Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota.

Authors:  Jia Sun; Laetitia Furio; Ramine Mecheri; Anne M van der Does; Erik Lundeberg; Loredana Saveanu; Yongquan Chen; Peter van Endert; Birgitta Agerberth; Julien Diana
Journal:  Immunity       Date:  2015-08-04       Impact factor: 31.745

8.  Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies.

Authors:  Vincent J Willey; Sheldon Kong; Bingcao Wu; Amit Raval; Todd Hobbs; Andrea Windsheimer; Gaurav Deshpande; Ozgur Tunceli; Brian Sakurada; Jonathan R Bouchard
Journal:  Am Health Drug Benefits       Date:  2018-09

9.  Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.

Authors:  Ryan M Thomas; Raad Z Gharaibeh; Josee Gauthier; Mark Beveridge; Jillian L Pope; Maria V Guijarro; Qin Yu; Zhen He; Christina Ohland; Rachel Newsome; Jose Trevino; Steven J Hughes; Mary Reinhard; Kathryn Winglee; Anthony A Fodor; Maria Zajac-Kaye; Christian Jobin
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

Review 10.  Global and regional estimates of the morbidity due to type I diabetes among children aged 0-4 years: a systematic review and analysis.

Authors:  Davies Adeloye; Kit Yee Chan; Natasha Thorley; Charlotte Jones; David Johnstone; Ari L'Heveder; Vanja Saftic; David Henderson; Mickey Chopra; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

View more
  63 in total

1.  Frailty is associated with poor prognosis after resection for pancreatic cancer.

Authors:  Kosuke Mima; Hiromitsu Hayashi; Shigeki Nakagawa; Takashi Matsumoto; Shotaro Kinoshita; Kazuki Matsumura; Fumimasa Kitamura; Norio Uemura; Yosuke Nakao; Rumi Itoyama; Takayoshi Kaida; Katsunori Imai; Yo-Ichi Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-07-07       Impact factor: 3.402

2.  Characteristics of the Gut Microbiota and Metabolism in Patients With Latent Autoimmune Diabetes in Adults: A Case-Control Study.

Authors:  Yuanyuan Fang; Chenhong Zhang; Hongcai Shi; Wei Wei; Jing Shang; Ruizhi Zheng; Lu Yu; Pingping Wang; Junpeng Yang; Xinru Deng; Yun Zhang; Shasha Tang; Xiaoyang Shi; Yalei Liu; Huihui Yang; Qian Yuan; Rui Zhai; Huijuan Yuan
Journal:  Diabetes Care       Date:  2021-10-07       Impact factor: 19.112

Review 3.  The Cancer Microbiome: Recent Highlights and Knowledge Gaps.

Authors:  Reece J Knippel; Julia L Drewes; Cynthia L Sears
Journal:  Cancer Discov       Date:  2021-08-16       Impact factor: 39.397

Review 4.  Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.

Authors:  A Fierabracci; A Arena; F Toto; N Gallo; A Puel; M Migaud; M Kumar; K G Chengappa; R Gulati; V S Negi; C Betterle
Journal:  J Endocrinol Invest       Date:  2020-08-07       Impact factor: 4.256

5.  Dysbiotic gut microbiota in pancreatic cancer patients form correlation networks with the oral microbiota and prognostic factors.

Authors:  Hiroki Matsukawa; Noriho Iida; Kazuya Kitamura; Takeshi Terashima; Jun Seishima; Isamu Makino; Takayuki Kannon; Kazuyoshi Hosomichi; Taro Yamashita; Yoshio Sakai; Masao Honda; Tatsuya Yamashita; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 6.  The microbiome, genetics, and gastrointestinal neoplasms: the evolving field of molecular pathological epidemiology to analyze the tumor-immune-microbiome interaction.

Authors:  Kosuke Mima; Keisuke Kosumi; Yoshifumi Baba; Tsuyoshi Hamada; Hideo Baba; Shuji Ogino
Journal:  Hum Genet       Date:  2020-11-12       Impact factor: 4.132

7.  Therapeutic potential of microbial modulation in pancreatic cancer.

Authors:  Vidhi Chandra; Florencia McAllister
Journal:  Gut       Date:  2021-04-27       Impact factor: 23.059

Review 8.  Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer.

Authors:  Julie Veziant; Romain Villéger; Nicolas Barnich; Mathilde Bonnet
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

Review 9.  Immunotherapy in Pancreatic Adenocarcinoma: Beyond "Copy/Paste".

Authors:  Robert Hester; Pawel K Mazur; Florencia McAllister
Journal:  Clin Cancer Res       Date:  2021-06-30       Impact factor: 12.531

Review 10.  Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.

Authors:  Amy D Proal; Michael B VanElzakker
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.